Can yoga rewire the brain to ease lasting grief in older adults?
NCT ID NCT07738133
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This study explores whether Iyengar yoga can reduce symptoms of prolonged grief disorder in adults aged 40 and older who have lost a loved one. Participants will take part in weekly yoga classes or a health education group, and researchers will measure changes in grief severity and brain activity. The goal is to understand how yoga might help the brain adapt after loss and potentially offer a new way to support those struggling with grief.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Iyengar Yoga
- What this could lead to
- If yoga proves effective, it could offer a non-drug way to ease prolonged grief in older adults and reveal brain targets for new therapies.
- What could go wrong
- This is an early-stage trial, so results may not be conclusive. Yoga may not outperform the control group, and benefits could vary by individual.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 126 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Jun 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 89 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female greater than or equal to 40 years of age * Bereavement \>6 months * Score greater than or equal to 25 on the Inventory of Complicated Grief (ICG) * Presence of PGD (subsyndromal and syndromal) * Adequate visual and auditory acuity Exclusion Criteria: * Delirium/unstable medical conditions * Lifetime history of neurological illnesses: seizures, stroke, dementia of any -etiology, severe head injury, brain tumor or surgery * Serious back, joint or neck injuries within the past 3 months * Currently practicing yoga * Gross structural abnormalities on T1-weighted images * Lifetime history of the following psychiatric disorders: bipolar or psychotic -disorders, including psychotic depression * Current alcohol/drug abuse or dependence * Magnetic resonance imaging (MRI) contraindications * Acute suicidality
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prolonged grief disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.